{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:58:13Z","timestamp":1794855493149,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75735-w","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:53:52Z","timestamp":1785164032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Personalized Phage Therapy in an ICU Patient with Polymicrobial Pulmonary Infections: a case from a single-arm trial"],"prefix":"10.1038","volume":"17","author":[{"given":"Yongxin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3975-9079","authenticated-orcid":false,"given":"Jianhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1244-0030","authenticated-orcid":false,"given":"Nannan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"75735_CR1","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00134-020-05980-0","volume":"46","author":"L Papazian","year":"2020","unstructured":"Papazian, L., Klompas, M. & Luyt, C. E. Ventilator-associated pneumonia in adults: a narrative review. Intensive Care Med 46, 888\u2013906 (2020).","journal-title":"Intensive Care Med"},{"key":"75735_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50805-z","volume":"15","author":"F Howroyd","year":"2024","unstructured":"Howroyd, F. et al. Ventilator-associated pneumonia: pathobiological heterogeneity and diagnostic challenges. Nat. Commun. 15, 6447 (2024).","journal-title":"Nat. Commun."},{"key":"75735_CR3","doi-asserted-by":"crossref","unstructured":"Mitropoulou, G. et al. Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations. Eur. Respir. Rev. 31, 10.1183\/16000617.0121-2022 (2022).","DOI":"10.1183\/16000617.0121-2022"},{"key":"75735_CR4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1080\/22221751.2021.1902754","volume":"10","author":"N Wu","year":"2021","unstructured":"Wu, N. et al. Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients. Emerg. Microbes Infect. 10, 612\u2013618 (2021).","journal-title":"Emerg. Microbes Infect."},{"key":"75735_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59806-y","volume":"16","author":"C Weissfuss","year":"2025","unstructured":"Weissfuss, C. et al. Adjunctive phage therapy improves antibiotic treatment of ventilator-associated-pneumonia with Pseudomonas aeruginosa. Nat. Commun. 16, 4500 (2025).","journal-title":"Nat. Commun."},{"key":"75735_CR6","doi-asserted-by":"publisher","first-page":"107731","DOI":"10.1016\/j.ijantimicag.2026.107731","volume":"67","author":"N Li","year":"2026","unstructured":"Li, N., Yang, Q., Hu, B., Zhu, T. & Wu, N. Phage therapy in China: Arming the One Health approach. Int J. Antimicrob. Agents 67, 107731 (2026).","journal-title":"Int J. Antimicrob. Agents"},{"key":"75735_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cid\/ciac453","volume":"76","author":"RM Dedrick","year":"2023","unstructured":"Dedrick, R. M. et al. Phage therapy of mycobacterium infections: compassionate use of phages in 20 patients with drug-resistant mycobacterial disease. Clin. Infect. Dis. 76, 103\u2013112 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"75735_CR8","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41591-025-03678-8","volume":"31","author":"BK Chan","year":"2025","unstructured":"Chan, B. K. et al. Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis. Nat. Med 31, 1494\u20131501 (2025).","journal-title":"Nat. Med"},{"key":"75735_CR9","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/cid\/ciad335","volume":"77","author":"SI Green","year":"2023","unstructured":"Green, S. I. et al. A retrospective, observational study of 12 cases of expanded-access customized phage therapy: production, characteristics, and clinical outcomes. Clin. Infect. Dis. 77, 1079\u20131091 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"75735_CR10","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","volume":"9","author":"JP Pirnay","year":"2024","unstructured":"Pirnay, J. P. et al. Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat. Microbiol 9, 1434\u20131453 (2024).","journal-title":"Nat. Microbiol"},{"key":"75735_CR11","doi-asserted-by":"crossref","unstructured":"Popova, A. V. et al. Specific interaction of novel friunavirus phages encoding tailspike depolymerases with corresponding acinetobacter baumannii capsular types. J. Virol. 95, 10.1128\/JVI.01714-20 (2021).","DOI":"10.1128\/JVI.01714-20"},{"key":"75735_CR12","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1128\/AAC.01388-10","volume":"55","author":"S Coyne","year":"2011","unstructured":"Coyne, S., Courvalin, P. & Perichon, B. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob. Agents Chemother. 55, 947\u2013953 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"75735_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1354681","volume":"14","author":"B Van Nieuwenhuyse","year":"2024","unstructured":"Van Nieuwenhuyse, B. et al. Case report: Personalized triple phage-antibiotic combination therapy to rescue necrotizing fasciitis caused by Panton-Valentine leukocidin-producing MRSA in a 12-year-old boy. Front Cell Infect. Microbiol 14, 1354681 (2024).","journal-title":"Front Cell Infect. Microbiol"},{"key":"75735_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04384-22","volume":"11","author":"H Geng","year":"2023","unstructured":"Geng, H. et al. Resistance of Klebsiella pneumoniae to Phage hvKpP3 Due to High-Molecular Weight Lipopolysaccharide Synthesis Failure. Microbiol Spectr. 11, e0438422 (2023).","journal-title":"Microbiol Spectr."},{"key":"75735_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03631-22","volume":"11","author":"OY Timoshina","year":"2023","unstructured":"Timoshina, O. Y. et al. Loss of a branch sugar in the acinetobacter baumannii k3-type capsular polysaccharide due to frameshifts in the gtr6 glycosyltransferase gene leads to susceptibility to phage APK37.1. Microbiol Spectr. 11, e0363122 (2023).","journal-title":"Microbiol Spectr."},{"key":"75735_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31455-5","volume":"13","author":"M Liu","year":"2022","unstructured":"Liu, M. et al. Comparative genomics of Acinetobacter baumannii and therapeutic bacteriophages from a patient undergoing phage therapy. Nat. Commun. 13, 3776 (2022).","journal-title":"Nat. Commun."},{"key":"75735_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41564-020-00830-7","volume":"6","author":"F Gordillo Altamirano","year":"2021","unstructured":"Gordillo Altamirano, F. et al. Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials. Nat. Microbiol 6, 157\u2013161 (2021).","journal-title":"Nat. Microbiol"},{"key":"75735_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01393-24","volume":"15","author":"K Qin","year":"2024","unstructured":"Qin, K. et al. Phage-antibiotic synergy suppresses resistance emergence of Klebsiella pneumoniae by altering the evolutionary fitness. mBio 15, e0139324 (2024).","journal-title":"mBio"},{"key":"75735_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100891","volume":"66","author":"J He","year":"2023","unstructured":"He, J. et al. Opposite evolution of pathogenicity driven by in vivo wzc and wcaJ mutations in ST11-KL64 carbapenem-resistant Klebsiella pneumoniae. Drug Resist Updat 66, 100891 (2023).","journal-title":"Drug Resist Updat"},{"key":"75735_CR20","doi-asserted-by":"publisher","first-page":"e1009291","DOI":"10.1371\/journal.ppat.1009291","volume":"17","author":"Y Talyansky","year":"2021","unstructured":"Talyansky, Y. et al. Capsule carbohydrate structure determines virulence in Acinetobacter baumannii. PLoS Pathog. 17, e1009291 (2021).","journal-title":"PLoS Pathog."},{"key":"75735_CR21","doi-asserted-by":"publisher","first-page":"1601 e1601","DOI":"10.1016\/j.cmi.2023.08.022","volume":"29","author":"J Li","year":"2023","unstructured":"Li, J. et al. Development of phage resistance in multidrug-resistant Klebsiella pneumoniae is associated with reduced virulence: a case report of a personalised phage therapy. Clin. Microbiol Infect. 29, 1601 e1601\u20131601 e1607 (2023).","journal-title":"Clin. Microbiol Infect."},{"key":"75735_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.108075","volume":"160","author":"H Yan","year":"2025","unstructured":"Yan, H. et al. Personalized aerosolized bacteriophage treatment of a pulmonary infection due to carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae in an infant. Int J. Infect. Dis. 160, 108075 (2025).","journal-title":"Int J. Infect. Dis."},{"key":"75735_CR23","first-page":"60","volume":"1","author":"MW Wojewodzic","year":"2020","unstructured":"Wojewodzic, M. W. Bacteriophages could be a potential game changer in the trajectory of coronavirus disease (COVID-19). Phage (N. Rochelle) 1, 60\u201365 (2020).","journal-title":"Phage (N. Rochelle)"},{"key":"75735_CR24","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1080\/22221751.2021.2002671","volume":"10","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture. Emerg. Microbes Infect. 10, 2205\u20132219 (2021).","journal-title":"Emerg. Microbes Infect."},{"key":"75735_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39370-z","volume":"14","author":"T Kohler","year":"2023","unstructured":"Kohler, T. et al. Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa. Nat. Commun. 14, 3629 (2023).","journal-title":"Nat. Commun."},{"key":"75735_CR26","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1121","volume":"143","author":"J Pugin","year":"1991","unstructured":"Pugin, J. et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic \u201cblind\u201d bronchoalveolar lavage fluid. Am. Rev. Respir. Dis. 143, 1121\u20131129 (1991).","journal-title":"Am. Rev. Respir. Dis."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75735-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75735-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75735-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:04:55Z","timestamp":1785513895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75735-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75735"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75735-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Q.Y., J.F.L., X.Z., C.C., Z.Z., H.Z., and N.W. are employees of CreatiPhage Biotechnology. Q.Y. and J.F.L. participated in data analysis, and X.Z., C.C., Z.Z., and H.Z. were responsible for phage preparation. Prior to joining CreatiPhage, N.W. was affiliated with the Shanghai Institute of Phage and jointly supervised the implementation and analysis of this case. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7411"}}